| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/22/2011 | US7893320 Method for producing multiple unsaturated fatty acids in plants |
| 02/22/2011 | US7893319 Nucleotide sequences mediating plant male fertility and method of using same |
| 02/22/2011 | US7893318 Nucleotide sequences mediating plant male fertility and method of using same |
| 02/22/2011 | US7893317 Nucleotide sequences mediating plant male fertility and method of using same |
| 02/22/2011 | US7893316 Method for reconstructing a non-human mammal embryo with foetal adult differentiated cells |
| 02/22/2011 | US7893250 Demethylated and/or oxidized membrane DNA |
| 02/22/2011 | US7893249 Deprotection and purification of oligonucleotides and their derivatives |
| 02/22/2011 | US7893247 siRNA targeting spleen tyrosine kinase |
| 02/22/2011 | US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 02/22/2011 | US7893245 Interfering RNA molecules |
| 02/22/2011 | US7893243 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 02/22/2011 | US7893242 Oligonucleotide compositions and their use to induce apoptosis |
| 02/22/2011 | US7893239 Recombinant expression cassettes with a fungal 3' termination sequence that function in plants |
| 02/22/2011 | US7893238 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/22/2011 | US7893237 Haemophilus influenzae type IV pili |
| 02/22/2011 | US7893236 Soybean isopentenyl transferase genes and methods of use |
| 02/22/2011 | US7893235 Nucleotide sequences coding orphan receptor for use in identifying modulators for prevention and treatment of diabetes |
| 02/22/2011 | US7893234 EPSP synthase highly tolerant of glyphosate |
| 02/22/2011 | US7893233 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 02/22/2011 | US7893232 Lipase |
| 02/22/2011 | US7893231 A recombinant mutant of coryneform bacteria with a gene coding for a polypeptide having 2-methylcitrate dehydratase activity and an amino acid sequence in which one of the proteinogenic amino acids except L-proline is present at position 272; L-Lysine/L-tryptophan-containing feed additive; nutrients |
| 02/22/2011 | US7893229 Peptides comprising repetitive units of amino acids and DNA sequences encoding the same |
| 02/22/2011 | US7893228 Compositions and methods for using a solid support to purify RNA |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7893211 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 02/22/2011 | US7893209 Slo2, novel potassium channel proteins from human brain |
| 02/22/2011 | US7893207 Fluorescent and colored proteins, and polynucleotides that encode these proteins |
| 02/22/2011 | US7893205 Hemopoietin receptor protein, NR12 |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893201 Hemopoietin receptor protein, NR12 |
| 02/22/2011 | US7893054 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7893035 Multicistronic constructs with siRNA to inhibit tumors |
| 02/22/2011 | US7893034 increasing the sensitivity of a cell or tissues to cytotoxic cancer therapy with a naturally occurring nucleic acids |
| 02/22/2011 | US7893032 NgR variants and compositions thereof for suppressing axonal growth inhibition |
| 02/22/2011 | US7893016 Stabilisation of double-stranded nucleic acids using proteins |
| 02/22/2011 | US7893007 Directed evolution of novel binding proteins |
| 02/22/2011 | US7892838 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity |
| 02/22/2011 | US7892837 Method for transferring molecules in vital cells by means of laser beams and arrangement for carrying out said method |
| 02/22/2011 | US7892836 includes an inner capillary tube disposed concentrically within an outer capillary tube with the input end of the inner tube connected to a channel through which a continuous flow of high speed helium gas carrying ballistic particles is introduced |
| 02/22/2011 | US7892835 Pluripotent stem cell growing method |
| 02/22/2011 | US7892834 Cellular signal-responsive gene transcriptional regulation system |
| 02/22/2011 | US7892833 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 02/22/2011 | US7892832 Genetically engineering preferential bacteria; obtain bacteria that is stable containing desirable output traits, transform with expression vector, monitor bacteria for intensified mutation activity |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892825 Method of protein production in yeast |
| 02/22/2011 | US7892824 Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), and X-linked Dilated Cardiomyopathy (XLDC); retains the N-terminal domain, the cysteine-rich domain, two or more repeats of the mid-rod domain, and two or more hinges of the mid-rod domain of a full-length dystrophin protein |
| 02/22/2011 | US7892823 Targeting vector which utilizes homologous recombination to insert hypoxanthine-guanine phosphoriboysyltransferase gene into cells; tissue-targeted therapy; site-directed mutagenesis |
| 02/22/2011 | US7892822 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/22/2011 | US7892818 Method and kit for the determination of cellular activation profiles |
| 02/22/2011 | US7892812 Chrysosporium cellulase and methods of use |
| 02/22/2011 | US7892810 Corynephage integrase-based site-specific insertion vector system |
| 02/22/2011 | US7892808 Protease variants |
| 02/22/2011 | US7892804 Arabinitol dehydrogenases from Neurospora crassa |
| 02/22/2011 | US7892803 Gene and uses therefor to modify pasture qualities of crops |
| 02/22/2011 | US7892798 Nucleic acid molecules encoding metabolic regulatory proteins from Corynebacterium glutamicum, useful for increasing the production of methionone by a microorganism |
| 02/22/2011 | US7892796 Solid support assay systems and methods utilizing non-standard bases |
| 02/22/2011 | US7892793 Allele-specific RNA interference |
| 02/22/2011 | US7892791 Fluorescent protein and chromoprotein |
| 02/22/2011 | US7892787 Method for production of recombinant growth hormone in form of hybrid protein |
| 02/22/2011 | US7892786 Methods for expression and purification of immunotoxins |
| 02/22/2011 | US7892778 Generating transgenic worms comprising construct which expresses gamma -secretase; identifying modulators for treatment and prevention of alzhemier's disease |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892772 For engineering products which modulate trafficking and destruction of target proteins inside cells; host cells; drug screening |
| 02/22/2011 | US7892769 Processing of EphA4 polypeptide by γ-secretase activity |
| 02/22/2011 | US7892754 Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof |
| 02/22/2011 | US7892736 Selecting a domestic animal for having desired genotypic properties bytesting the animal for the presence of a parentally imprinted quantitative trait locus; particularly selecting properties related to muscle mass, fat deposition, sow prolificacy, and/or sow longevity in pigs |
| 02/22/2011 | US7892733 Response element regions |
| 02/22/2011 | US7892732 Method of performing PCR amplification on a microarray |
| 02/22/2011 | US7892730 Nucleotide sequences coding polypeptide for use in the treatment of and detection of cancer |
| 02/22/2011 | US7892727 Chemokine-binding protein and methods of use |
| 02/22/2011 | US7892583 Initiation of fermentation |
| 02/22/2011 | US7892569 agents that affect the activity and/or expression of CXCL16 can be used to alter the uptake of D-type CpG oligodeoxynucleotides; to decrease an immune response; antagonist of ADAM-10 is GW280264X, G1254023X or GM6001 |
| 02/22/2011 | US7892564 Recombinant infectious laryngotracheitis virus and uses thereof |
| 02/22/2011 | US7892560 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/22/2011 | US7892557 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
| 02/22/2011 | US7892554 Using immunoglobulin fusion to deliver effector cells; tissue targeted therapy; antitumor agents |
| 02/22/2011 | US7892549 Treatment with anti-ErbB2 antibodies |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892543 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma |
| 02/22/2011 | US7892539 Modulation of an innate immune response by altering TRIAL-R signaling |
| 02/22/2011 | US7892533 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/22/2011 | US7892532 Intracellular delivery of osteoinductive proteins and peptides |
| 02/22/2011 | CA2554195C Peptide originating in epidermal growth factor receptor (egfr) |
| 02/22/2011 | CA2495482C Novel peptide-forming enzyme gene |
| 02/22/2011 | CA2470564C Recombinant polypeptides |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2433281C Rapid and quantitative proteome analysis and related methods |
| 02/22/2011 | CA2431881C Polypeptide inducing hiv-neutralising antibodies |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2409208C Method for examining wt1-related disease |
| 02/22/2011 | CA2404429C Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 02/22/2011 | CA2399504C Methods for producing temperature-sensitive morbillivirus |
| 02/22/2011 | CA2392685C Antisense antibacterial method and composition |
| 02/22/2011 | CA2356255C Use of a xylanase in the preparation of dough |
| 02/22/2011 | CA2350882C Transfection reagents |
| 02/22/2011 | CA2335730C Method for marking a ribonucleic acid and resulting marked rna fragments |
| 02/22/2011 | CA2310806C Pectin degrading enzymes from bacillus licheniformis |
| 02/22/2011 | CA2266334C Method for determining ion channel activity of a substance |